| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Plasma kallikrein |
|---|
| Ligand | BDBM283534 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | In Vitro Contact Cellular Assay |
|---|
| EC50 | <100±n/a nM |
|---|
| Citation |  McDonald, A; Qian, S Therapeutic inhibitory compounds US Patent US10023557 Publication Date 7/17/2018 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Plasma kallikrein |
|---|
| Name: | Plasma kallikrein |
|---|
| Synonyms: | Fletcher factor | KLK3 | KLKB1 | KLKB1_HUMAN | Kallikrein | Kininogenin | Plasma kallikrein heavy chain | Plasma kallikrein light chain | Plasma prekallikrein |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 71391.16 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P03952 |
|---|
| Residue: | 638 |
|---|
| Sequence: | MILFKQATYFISLFATVSCGCLTQLYENAFFRGGDVASMYTPNAQYCQMRCTFHPRCLLF
SFLPASSINDMEKRFGCFLKDSVTGTLPKVHRTGAVSGHSLKQCGHQISACHRDIYKGVD
MRGVNFNVSKVSSVEECQKRCTSNIRCQFFSYATQTFHKAEYRNNCLLKYSPGGTPTAIK
VLSNVESGFSLKPCALSEIGCHMNIFQHLAFSDVDVARVLTPDAFVCRTICTYHPNCLFF
TFYTNVWKIESQRNVCLLKTSESGTPSSSTPQENTISGYSLLTCKRTLPEPCHSKIYPGV
DFGGEELNVTFVKGVNVCQETCTKMIRCQFFTYSLLPEDCKEEKCKCFLRLSMDGSPTRI
AYGTQGSSGYSLRLCNTGDNSVCTTKTSTRIVGGTNSSWGEWPWQVSLQVKLTAQRHLCG
GSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILNLSDITKDTPFSQIKEIIIHQNYKVSEG
NHDIALIKLQAPLNYTEFQKPICLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNI
PLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGE
GCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA
|
|
|
|---|
| BDBM283534 |
|---|
| n/a |
|---|
| Name | BDBM283534 |
|---|
| Synonyms: | N-((1-amino-7-methylisoquinolin-6-yl)methyl)- 2-((3-(trifluoromethyl)quinolin-6- yl)methyl)isonicotinamide | US10023557, Example 183 | US10308637, Example 183 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C28H22F3N5O |
|---|
| Mol. Mass. | 501.5024 |
|---|
| SMILES | Cc1cc2c(N)nccc2cc1CNC(=O)c1ccnc(Cc2ccc3ncc(cc3c2)C(F)(F)F)c1 |
|---|
| Structure | 
|
|---|
Search and Browse
